Literature DB >> 2499165

Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts.

K Fuller1, T J Chambers.   

Abstract

Arachidonic acid metabolites (eicosanoids) have major effects on bone but their role is unclear. Many are known to stimulate bone resorption in organ culture, but paradoxically, previous work has suggested that at least some of them act as direct inhibitors of osteoclastic function. In an attempt to clarify the role of eicosanoids in bone physiology, we have defined the duration of action and relative potencies of prostaglandin (PG) E1 and E2 and have extended the range of eicosanoids tested on isolated osteoclasts. We have found that PGE1 and PGE2 inhibited bone resorption by isolated osteoclasts for at least 6 h. Inhibition was followed by recovery to control, not supranormal levels. Bone resorption was inhibited in the range 10(-5)-10(-9) M for PGE1 and PGE2, and the rank order as resorption inhibitors was PGE1 greater than 6-keto PGE1 greater than PGE2 greater than PGA2 greater than PGB2. None of the products of lipoxygenase metabolism showed a significant direct effect. The effects of PGE1 and PGE2 were not antagonistic. Prostaglandin production does not seem to be implicated as a second messenger for the action of calcitonin. Although inhibition of osteoclasts by PGs was less prolonged than that observed in the presence of calcitonin, the sensitivity of osteoclasts to inhibition by PGs, and the duration of the effect without subsequent direct stimulation, suggests that inhibition of osteoclastic resorption is a major physiological role of PG production in bone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499165     DOI: 10.1002/jbmr.5650040212

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors.

Authors:  E M Greenfield; J I Alvarez; E A McLaurine; M J Oursler; H C Blair; P Osdoby; S L Teitelbaum; F P Ross
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

2.  Serum blocks the osteolytic effect of cortisol in neonatal mouse calvaria.

Authors:  C Lowe; D H Gray; I R Reid
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

3.  Pitfalls in pit measurement.

Authors:  A Boyde; S J Jones
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 4.  Infection, inflammation, and bone regeneration: a paradoxical relationship.

Authors:  M V Thomas; D A Puleo
Journal:  J Dent Res       Date:  2011-01-19       Impact factor: 6.116

5.  Immunohistochemical demonstration of prostaglandins in various tissues of the rat.

Authors:  M Miyauchi; T Takata; I Ogawa; H Ito; J Kobayashi; H Nikai; N Ijuhin
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

6.  Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats.

Authors:  T Takagi; T Yamamoto; S Asano; H Tamaki
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

Review 7.  Prostaglandins: mechanisms of action and regulation of production in bone.

Authors:  L G Raisz; C C Pilbeam; P M Fall
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

8.  The effect of sodium salicylate on the osteoclast-like cell formation and bone resorption in a mouse bone marrow culture.

Authors:  A Soekanto; K Ohya; H Ogura
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

9.  Loading and skeletal development and maintenance.

Authors:  P Bergmann; J J Body; S Boonen; Y Boutsen; J P Devogelaer; S Goemaere; J Kaufman; J Y Reginster; S Rozenberg
Journal:  J Osteoporos       Date:  2010-12-20

10.  Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosis.

Authors:  Yang-Hwei Tsuang; Jui-Sheng Sun; Li-Ting Chen; Samuel Chung-Kai Sun; San-Chi Chen
Journal:  J Orthop Surg Res       Date:  2006-10-07       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.